In focus · trending topic

Phrixus Carmeseal poloxamer

1 stories · following the connections

Phrixus Pharmaceuticals announces Phase 2 clinical trial of Poloxamer 188 NF in non-ambulatory patients with Duchenne muscular dystrophy

By Nasdaq OMXSep 14, 2017, 12:00 PM UTC